Lanzamiento Enero 2027

Ensayo controlado aleatorizado2025Financiación no declaradaAcceso abierto

Effects of topical ozonated olive oil on lipid profile, quality of life, wound healing and glycemic control in patients with diabetic foot ulcers: a randomized controlled trial

Vahedi S, Rahimi M, Shad TS, Khanchemehr Y, Ghoozlu KJ, Fallah S, Moradi M

Lipids in health and disease · 1 cita

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento
Consumo medido con
No se indica

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2025-09-29 · Lipids Health Dis · vol. 24 · número 1 · pág. 291
Editorial
BioMed Central
Citado
3 citas · más que el 88% de estudios similares · 1.8× el promedio de su campo
Referencias
33 trabajos
Acceso
Acceso abierto (revista) · CC-BY-NC-ND
Áreas de investigación
Diabetic Foot Ulcer Assessment and Management · Medical and Biological Ozone Research · Wound Healing and Treatments
Palabras clave
diabetic foot ulcer, ozonated olive oil, wound healing, glycemic control, lipid profile, quality of life, inflammation, type 2 diabetes, chronic wounds, HbA1c, C-reactive protein, interleukin-6, TNF-α, Bates-Jensen Wound Assessment Tool
MeSH
humans, diabetic foot, diabetes mellitus, type 2, ozone, blood glucose, lipids, administration, topical, wound healing, quality of life, adolescent, adult, aged, middle aged, female, male, young adult, olive oil, glycemic control, glycated hemoglobin

7 autores

  • Solmaz Vahedi🇮🇷Tehran University of Medical Sciences
  • Masome Rahimi🇮🇷Jahrom University of Medical Sciences
  • Tayebeh Sargazi Shad🇮🇷Zabol University of Medical Sciences
  • Yaser Khanchemehr🇮🇷Hormozgan University of Medical Sciences
  • Khadije Jahangasht Ghoozlu🇮🇷Babol University of Medical Sciences
  • Somayeh Fallah🇬🇧Edinburgh Napier University
  • Mahboobeh Moradi🇮🇷 · autor de correspondenciaGuilan University of Medical Sciences

Resumen

El texto original del estudio, en el idioma en que se publicó.

Introduction

Diabetic foot ulcers (DFUs) are a severe complication of diabetes, leading to infections, amputations, and reduced quality of life. Ozonated olive oil, combining ozone's antimicrobial properties with olive oil's biocompatibility, shows promise in chronic wound management. Limited evidence exists on its comprehensive effects in DFUs. This study evaluates its impact on wound healing, quality of life, glycemic control, lipid profiles, and inflammation.

Methods

A randomized controlled trial was conducted at a tertiary care center in Hormozgan Province (January-December 2024) with 123 adults (aged 18-75) with type-2 diabetes and Wagner grade 1-2 DFUs. Participants were randomized (1:1) to receive daily topical ozonated olive oil (50 g/m³, 5 mL) or standard care for 4 weeks. Outcomes included wound severity (Bates-Jensen Wound Assessment Tool [BWAT]), quality of life (Diabetes Quality of Life Questionnaire [DQOL]), glycemic control (Glycated Hemoglobin [HbA1c], Fasting Blood Glucose [FBG], Postprandial Glucose [PPG]), lipid profiles (Low-Density Lipoprotein [LDL], High-Density Lipoprotein [HDL], Triglycerides [TG], Total Cholesterol), and inflammatory markers (High-Sensitivity C-Reactive Protein [hs-CRP], Interleukin-6 [IL-6], Tumor Necrosis Factor-alpha [TNF-α]). Assessments occurred at baseline, post-intervention, and 4 weeks post-intervention. Linear Mixed Models (LMM) and Analysis of Covariance (ANCOVA) analyzed outcomes, adjusting for baseline values.

Results

The intervention group (n = 62) showed significant improvements compared to controls (n = 61). Bates-Jensen scores decreased (22.3 ± 4.5 vs. 26.1 ± 4.9, p 0.05).

Conclusion

Topical ozonated olive oil significantly enhances wound healing, quality of life, glycemic control, and reduces inflammation in DFU patients. Its affordability and efficacy make it a promising adjunctive therapy. Further studies should explore long-term effects and mechanisms. It offers a scalable solution for DFU management.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY-NC-ND).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.